To ask Mr Chancellor of the Exchequer, if the Government will take steps to ensure that the proceeds of fines imposed by the Competition and Markets Authority on pharmaceutical companies will be invested in the NHS.
12 December 2016
As with other fine income, fines levied by the CMA for breaches of competition law are returned to the Consolidated Fund. Receipts from this fine will therefore help fund the £10bn increase in NHS funding set out at the Spending Review. A separate process is available for parties to recover damages suffered as a result of anti-competitive behaviour through the courts.